| Literature DB >> 21559373 |
Alfredo Mayor1, Abdul Hafiz, Quique Bassat, Eduard Rovira-Vallbona, Sergi Sanz, Sónia Machevo, Ruth Aguilar, Pau Cisteró, Betuel Sigaúque, Clara Menéndez, Pedro L Alonso, Chetan E Chitnis.
Abstract
INTRODUCTION: Severe malaria has been attributed partly to the sequestration of Plasmodium falciparum-infected erythrocytes (IEs) in the microvasculature of vital host organs. Identification of P. falciparum cytoadherence phenotypes that are associated with severe malaria may lead to the development of novel strategies against life-threatening malaria. METHODS ANDEntities:
Mesh:
Substances:
Year: 2011 PMID: 21559373 PMCID: PMC3084855 DOI: 10.1371/journal.pone.0019422
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical and biological characteristics of the study participants at the time of admission.
| Severe malaria | Non-severe malaria | ||
| Patient's characteristics | n = 46 | n = 46 |
|
|
| |||
| Age (months) | 32.5 (17–43) | 32 (17–42) | .871 |
| Males, n (%) | 31 (67.4) | 31 (67.4) | 1.000 |
|
| |||
| Anti-pyretic, n (%) | 3 (6) | 0 (0) | .083 |
| Antibiotic, n (%) | 2 (4%) | 1 (2) | .564 |
| Antimalarial, n (%) | 1 (2) | 0 (0) | .317 |
|
| |||
| Temperature (°C) | 38.6 (37.9–39.2) | 38.2 (36.8–39.6) | .880 |
| Weight (Kg) | 11.4 (9.4–13.2) | 11.9 (10.0–12.9) | 1.000 |
| Splenomegaly, n (%) | 23 (50.0) | 10 (21.7) | .067 |
| Hepatomegaly, n (%) | 8 (17.4) | 2 (43.5) | .033 |
| Previous days of fever | 1 (1–2) | 1 (1–2) | .860 |
| Previous days of cough | 1 (0.5–1) | 1 (0–1) | .250 |
| Previous days of vomits | 0 (0–0) | 1 (1–1) | .250 |
|
| |||
| Microscopic parasitaemia (103/µL) | 53.5 (28.1–129.4) | 40.5 (18.2–73.7) | .007 |
| Multiplicity of infection | 3 (3–4) | 3 (2–4) | .405 |
| Packed cell volume (%) | 28 (16–32) | 32 (28–34) | .019 |
| Platelets (109/L) | 116 (76–184) | 143 (92–181) | .164 |
| Glucose (mM) | 6.0 (5.2–7.0) | 5.9 (5.4–6.8) | .532 |
| White blood cells (109/L) | 10.1 (7.4–12.7) | 5.9 (5.4–6.8) | .059 |
| Lymphocytes (%) | 31.4 (21.3–43.1) | 37.4 (23.6–50.6) | .014 |
| Neutrophiles (%) | 63.9 (46.2–71.1) | 56.5 (38.3–65.9) | .065 |
| Creatinin (µ/L) | 35 (30–38) | 34 (30–38) | .542 |
| Bilirubin (µM) | 24 (17–38) | 15 (10–24) | .009 |
| ALT (µ/L) | 33 (21–39) | 25 (18–35) | .371 |
| Lactate (mM) | 3.7 (2.3–5.0) | 2.4 (1.9–3.7) | .009 |
|
| |||
| Prostration, n (%) | 37 (80) | - | |
| ARD, n (%) | 19 (41) | - | |
| Severe anemia, n (%) | 14 (30) | - | |
| Multiple seizures, n (%) | 13 (28) | - | |
| Cerebral malaria, n (%) | 3 (6) | - | |
| Hypoglycemia, n (%) | 2 (4) | - |
All continuous data is presented as the Median (Interquartile range).
ALT: Alanine aminotransferase; ARD: Acidosis or respiratory distress; IQR: Interquartile Range.
, McNemar's chi-squared (categorical) and Singtest (continuous).
Number (%) of isolates showing cytoadherence in children with severe and non-severe malaria.
| Clinical malaria | Rosetting | PM-Clumping | CD36 | ICAM1 | gC1qR | Duffy |
|
| 15 | 24 (52.2) | 39 (84.8) | 18 (39.1) | 17 (36.9) | 2 (4.3) |
|
| 16 | 36 (78.3) | 41 (89.1) | 23 (50.0) | 22 (47.8) | 1 (2.2) |
|
| .808 |
| .527 | .297 | .297 | .564 |
|
| 13 | 20 (54.0) | 31 (83.8) | 14 (37.8) | 13 (35.1) | 1 (2.7) |
|
| 13 | 29 (78.5) | 33 (89.2) | 18 (48.7) | 17 (45.9) | 1 (2.7) |
|
| 1.000 |
| .479 | .355 | .355 | 1.000 |
|
| 5 | 11 (57.9) | 17 (89.5) | 9 (47.4) | 9 (47.4) | 1 (5.3) |
|
| 7 | 15 (78.9) | 17 (89.5) | 8 (42.1) | 5 (26.3) | 0 (0.0) |
|
| .317 | .157 | 1.000 | .781 | .205 | .317 |
|
| 2 | 8 (57.1) | 13 (92.8) | 6 (42.9) | 5 (35.7) | 2 (14.3) |
|
| 6 | 13 (92.8) | 12 (85.7) | 6 (42.8) | 6 (42.9) | 0 (0.0) |
|
|
|
| .564 | 1.000 | .739 | .157 |
|
| 4 (30.8) | 5 (38.5) | 8 (61.5) | 5 (38.5) | 2 (15.4) | 0 (0.0) |
|
| 4 (30.8) | 9 (84.6) | 11 (84.6) | 9 (69.2) | 6 (46.2) | 1 (7.7) |
|
| 1.000 | .206 | .179 | .157 |
| 0.317 |
: 3 missing;
: 1 missing.
PM-Clumping: Platelet-mediated clumping (unadjusted); ARD: Acidosis and/or respiratory distress.
Median (interquartile range) intensities of cytoadherence phenotypes by clinical malaria manifestation.
| Clinical malaria | Rosetting | PM-Clumping | CD36 | ICAM1 | gC1qR |
|
| 0.6 | 0.2 (0.0; 8.7) | 178.1 (50.0; 405.0) | 2.5 (0.0; 40.0) | 0.0 (0.0; 45.0) |
|
| 1.0 | 5.1 (0.4; 20.2) | 123.4 (50.0; 245.0) | 15 (0.0; 55.0) | 8.5 (0.0; 70.0) |
|
| .627 |
| 1.000 | .499 | .229 |
|
| 0.6 | 0.2 (0.0; 8.7) | 171.6 (50.0; 405.0) | 0.0 (0.0; 45.0) | 0.0 (0.0; 48.6) |
|
| 1.0 | 4.7 (0.4; 20.4) | 127.1 (50.0; 245.0) | 10.0 (0.0; 55.0) | 0.0 (0.0; 75.0) |
|
| .855 |
| 1.000 | .701 | .327 |
|
| 0.2 | 2.6 (0.0; 16.9) | 275.0 (125.0; 533.4) | 15.0 (0.0; 54.2) | 0.0 (0.0; 55.0) |
|
| 1.1 | 6.3 (0.4; 20.2) | 110.0 (44.9; 175.0) | 0.0 (0.0; 35.0) | 0.0 (0.0; 75.0) |
|
| .791 | .323 | .167 | .803 | .267 |
|
| 0.9 | 0.3 (0.0; 11.6) | 178.1 (52.5; 423.5) | 0.0 (0.0; 37.9) | 0.0 (0.0; 45.0) |
|
| 2.0 | 6.6 (2.0; 15.5) | 75.0 (45.0; 175.0) | 0.0 (0.0; 47.7) | 2.5 (0.0; 55.0) |
|
| .065 | .092 | .424 | .549 | 1.000 |
|
| 0.2 (0.0; 2.2) | 2.6 (0.0; 16.9) | 275.0 (125.0; 533.4) | 15.0 (0.0; 54.2) | 0.0 (0.0; 55.0) |
|
| 1.0 (0.2; 2.2) | 2.5 (0.0; 7.0) | 120.3 (45.0; 255.0) | 22.4 (0.0; 51.6) | 12.0 (0.0; 50.0) |
|
| 1.000 | .774 | .774 | .387 | .125 |
: 3 missing;
: 1 missing.
PM-Clumping: Platelet-mediated clumping; UM: Uncomplicated malaria; SM: severe malaria; P: Prostration; ARD: Acidosis and/or respiratory distress; SA: Severe anemia; MS: Multiple seizures.
P-values for cytoadherence to Duffy receptors are as follows: 0.453 for SM; 1.000 for P, D and MS; and 0.625 for SA.